Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer

NCT03618043 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Cancer

Interventions

DRUG: SH-1028

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.